ABRAMS MICHAEL S 4
4 · NRX Pharmaceuticals, Inc. · Filed Feb 11, 2025
Insider Transaction Report
Form 4
ABRAMS MICHAEL S
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2025-02-07+50,000→ 50,000 totalExercise: $2.94Exp: 2035-02-07→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]Represents stock options ("Options") granted pursuant to the Issuer's 2021 Omnibus Incentive Plan. The Options shall vest in three equal annual installments beginning on February 7, 2026.